Paramita Chakraborty

1.8k total citations
44 papers, 902 citations indexed

About

Paramita Chakraborty is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Paramita Chakraborty has authored 44 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 16 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Paramita Chakraborty's work include Drug Transport and Resistance Mechanisms (11 papers), Metal complexes synthesis and properties (9 papers) and Immune Cell Function and Interaction (8 papers). Paramita Chakraborty is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Metal complexes synthesis and properties (9 papers) and Immune Cell Function and Interaction (8 papers). Paramita Chakraborty collaborates with scholars based in United States, India and Sweden. Paramita Chakraborty's co-authors include Soumitra Kumar Choudhuri, Shikhar Mehrotra, Sudipto Ganguly, Mitali Chatterjee, Kaushik Banerjee, Shilpak Chatterjee, Avijit Sarkar, Satyajit Das, Xue‐Zhong Yu and Soumya Basu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Paramita Chakraborty

41 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paramita Chakraborty United States 19 332 322 219 141 104 44 902
Daniela Buac United States 11 446 1.3× 327 1.0× 70 0.3× 218 1.5× 60 0.6× 11 825
Marta Martins Portugal 17 438 1.3× 162 0.5× 214 1.0× 81 0.6× 58 0.6× 33 889
Dongfan Song China 18 390 1.2× 353 1.1× 122 0.6× 193 1.4× 46 0.4× 32 910
Pavel B. Davidovich Russia 13 241 0.7× 154 0.5× 138 0.6× 108 0.8× 43 0.4× 31 548
Hellinida Thomadaki Greece 17 527 1.6× 337 1.0× 56 0.3× 133 0.9× 119 1.1× 22 899
Ada W.Y. Leung Canada 17 300 0.9× 275 0.9× 39 0.2× 174 1.2× 53 0.5× 30 720
Danae M. Sharp Australia 7 491 1.5× 363 1.1× 37 0.2× 97 0.7× 144 1.4× 10 865
Ceyda Açılan Türkiye 20 389 1.2× 391 1.2× 61 0.3× 242 1.7× 45 0.4× 46 941
Fredrik Lehmann Sweden 17 575 1.7× 210 0.7× 108 0.5× 278 2.0× 47 0.5× 59 1.1k
Lu Meng United States 18 619 1.9× 178 0.6× 130 0.6× 336 2.4× 43 0.4× 32 882

Countries citing papers authored by Paramita Chakraborty

Since Specialization
Citations

This map shows the geographic impact of Paramita Chakraborty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paramita Chakraborty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paramita Chakraborty more than expected).

Fields of papers citing papers by Paramita Chakraborty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paramita Chakraborty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paramita Chakraborty. The network helps show where Paramita Chakraborty may publish in the future.

Co-authorship network of co-authors of Paramita Chakraborty

This figure shows the co-authorship network connecting the top 25 collaborators of Paramita Chakraborty. A scholar is included among the top collaborators of Paramita Chakraborty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paramita Chakraborty. Paramita Chakraborty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oleinik, Natalia V., Paramita Chakraborty, Silvia G. Vaena, et al.. (2025). Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity. Cancer Research. 85(19). 3791–3811. 1 indexed citations
2.
Chakraborty, Paramita, et al.. (2024). Role of antioxidants in modulating anti-tumor T cell immune resposne. Advances in cancer research. 162. 99–124. 1 indexed citations
3.
Kim, Jisun, Do‐Sung Kim, Natalia V. Oleinik, et al.. (2024). Alterations of ceramide synthesis induce PD-L1 internalization and signaling to regulate tumor metastasis and immunotherapy response. Cell Reports. 43(8). 114532–114532. 4 indexed citations
4.
Zhang, Jie, Zhiwei Ye, Lars Bräutigam, et al.. (2023). A role for microsomal glutathione transferase 1 in melanin biosynthesis and melanoma progression. Journal of Biological Chemistry. 299(8). 104920–104920. 5 indexed citations
5.
Zhang, Jie, Zhiwei Ye, Paramita Chakraborty, et al.. (2023). Microsomal glutathione transferase 1 controls metastasis and therapeutic response in melanoma. Pharmacological Research. 196. 106899–106899. 9 indexed citations
6.
Gautam, Anupam, Paramita Chakraborty, Asima Mukhopadhyay, et al.. (2022). Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells. Cancer Research. 82(14). 2640–2655. 38 indexed citations
7.
Dwyer, Connor J., Paramita Chakraborty, Jason S. Pierce, et al.. (2021). Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients. Scientific Reports. 11(1). 14232–14232. 28 indexed citations
8.
Chatterjee, Shilpak, Paramita Chakraborty, Anusara Daenthanasanmak, et al.. (2018). Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clinical Cancer Research. 25(3). 1036–1049. 43 indexed citations
9.
Gummadidala, Phani M., James A. Burch, Paramita Chakraborty, et al.. (2018). Complementary feeding may pose a risk of simultaneous exposures to aflatoxin M1 and deoxynivalenol in Indian infants and toddlers: Lessons from a mini-survey of food samples obtained from Kolkata, India. Food and Chemical Toxicology. 123. 9–15. 26 indexed citations
10.
Chatterjee, Shilpak, Anusara Daenthanasanmak, Kyle Toth, et al.. (2016). Hybrid Th1/17 cells possess unique immuno-metabolic phenotype and surpiror anti-tumor activity. The Journal of Immunology. 196(1_Supplement). 214.18–214.18. 1 indexed citations
11.
Chakraborty, Paramita, Per Björk, Eva Källberg, et al.. (2015). Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid Cells. PLoS ONE. 10(12). e0145217–e0145217. 10 indexed citations
12.
Ganguly, Sudipto, Paramita Chakraborty, Kaushik Banerjee, & Soumitra Kumar Choudhuri. (2013). The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer. European Journal of Pharmaceutical Sciences. 51. 96–109. 48 indexed citations
13.
Banerjee, Kaushik, Satyajit Das, Sudipto Ganguly, et al.. (2013). A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer. European Journal of Pharmaceutical Sciences. 49(4). 737–747. 22 indexed citations
14.
Chakraborty, Paramita, Shilpak Chatterjee, Sudipto Ganguly, et al.. (2012). Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate. Journal of Leukocyte Biology. 91(4). 609–619. 36 indexed citations
15.
Chatterjee, Shilpak, Satyajit Das, Paramita Chakraborty, et al.. (2012). Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naïve CD4+ T cells. Immunobiology. 218(5). 718–724. 40 indexed citations
16.
Ganguly, Sudipto, Soumya Basu, Kaushik Banerjee, et al.. (2011). Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis. Molecular BioSystems. 7(5). 1701–1712. 32 indexed citations
17.
Ganguly, Sudipto, Kaushik Banerjee, Paramita Chakraborty, et al.. (2011). Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative. Biomedicine & Pharmacotherapy. 65(6). 387–394. 27 indexed citations
18.
Ganguly, Sudipto, Paramita Chakraborty, Kaushik Banerjee, et al.. (2011). Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo. BioMetals. 25(1). 149–163. 12 indexed citations
19.
Das, Satyajit, Sudipto Ganguly, Kaushik Banerjee, et al.. (2011). An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer. Dalton Transactions. 40(41). 10873–10873. 24 indexed citations
20.
Chattopadhyay, Basab, et al.. (2009). Synthesis, spectroscopic characterization, X-ray powder structure analysis, DFT study and in vitro anticancer activity of N-(2-methoxyphenyl)-3-methoxysalicylaldimine. Journal of Molecular Structure. 932(1-3). 90–96. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Buac Breakdown of academic impact, for papers by Marta Martins Breakdown of academic impact, for papers by Dongfan Song Breakdown of academic impact, for papers by Pavel B. Davidovich Breakdown of academic impact, for papers by Hellinida Thomadaki Breakdown of academic impact, for papers by Ada W.Y. Leung Breakdown of academic impact, for papers by Danae M. Sharp Breakdown of academic impact, for papers by Ceyda Açılan Breakdown of academic impact, for papers by Fredrik Lehmann Breakdown of academic impact, for papers by Lu Meng
Rankless by CCL
2026